These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21372250)

  • 1. Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy.
    Ando M; Yanagisawa N; Ajisawa A; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2011 Oct; 26(10):3224-9. PubMed ID: 21372250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of chronic kidney disease (CKD) and significant contributors to CKD in HIV-infected patients].
    Nakamura Y; Shibuya A; Suzuki H; Ando M
    Nihon Jinzo Gakkai Shi; 2008; 50(4):499-505. PubMed ID: 18546881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.
    Hall AM; Edwards SG; Lapsley M; Connolly JO; Chetty K; O'Farrell S; Unwin RJ; Williams IG
    Am J Kidney Dis; 2009 Dec; 54(6):1034-42. PubMed ID: 19783343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate ≥ 60 ml/min per 1.73 m2.
    Reynes J; Cournil A; Peyriere H; Psomas C; Guiller E; Chatron M; Cristol JP; Badiou S
    AIDS; 2013 May; 27(8):1295-302. PubMed ID: 23925378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.
    Wikman P; Safont P; Del Palacio M; Moreno A; Moreno S; Casado JL
    Nephrol Dial Transplant; 2013 Aug; 28(8):2073-81. PubMed ID: 23739150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.
    Choi AI; Rodriguez RA; Bacchetti P; Volberding PA; Havlir D; Bertenthal D; Bostrom A; O'Hare AM
    Clin Infect Dis; 2007 Dec; 45(12):1633-9. PubMed ID: 18190326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis.
    Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
    Kidney Int Suppl; 1994 Nov; 47():S101-4. PubMed ID: 7869656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients.
    Nauta FL; Bakker SJ; van Oeveren W; Navis G; van der Heide JJ; van Goor H; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2011 May; 57(5):733-43. PubMed ID: 21458900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.
    Vrouenraets SM; Fux CA; Wit FW; Garcia EF; Furrer H; Brinkman K; Hoek FJ; Abeling NG; Krediet RT; Reiss P;
    AIDS; 2011 Nov; 25(17):2149-55. PubMed ID: 21857491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
    Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
    Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.
    Bigé N; Lanternier F; Viard JP; Kamgang P; Daugas E; Elie C; Jidar K; Walker-Combrouze F; Peraldi MN; Isnard-Bagnis C; Servais A; Lortholary O; Noël LH; Bollée G
    Nephrol Dial Transplant; 2012 Mar; 27(3):1114-21. PubMed ID: 21745806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG; Engsig FN; Feldt-Rasmussen B; Kirk O; Kronborg G; Pedersen C; Gerstoft J; Obel N
    Scand J Infect Dis; 2012 Sep; 44(9):689-96. PubMed ID: 22680981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.
    Labarga P; Barreiro P; Martin-Carbonero L; Rodriguez-Novoa S; Solera C; Medrano J; Rivas P; Albalater M; Blanco F; Moreno V; Vispo E; Soriano V
    AIDS; 2009 Mar; 23(6):689-96. PubMed ID: 19262355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
    Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-associated kidney glomerular diseases: changes with time and HAART.
    Lescure FX; Flateau C; Pacanowski J; Brocheriou I; Rondeau E; Girard PM; Ronco P; Pialoux G; Plaisier E
    Nephrol Dial Transplant; 2012 Jun; 27(6):2349-55. PubMed ID: 22248510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients.
    Ando M; Yanagisawa N; Ajisawa A; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2011 Dec; 26(12):3923-9. PubMed ID: 21427068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial.
    Franz S; Regeniter A; Hopfer H; Mihatsch M; Dickenmann M
    Am J Kidney Dis; 2010 Feb; 55(2):335-43. PubMed ID: 19926370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
    Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.